Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with Astrazeneca and Avara Avlon about the (a) three year guarantee on enhanced redundancy payments and terms for staff agreed as part of the sale of the company for £1 in December 2016 and the (b) collapse of Avara Avalon.

My rt. hon. Friend the Secretary of State has had no discussions with Avara. This is a commercial matter which BEIS have been monitoring for some time, however we have not sought to intervene while staff consultation and the administration process are underway.

AstraZeneca announced on Wednesday that they have set aside funding of up to £12m, to be administered independently, to make sure their former employees at the Avlon site receive full severance should the ongoing administration of the site not generate enough funds to cover redundancy costs.